Skip to content

A Randomized, Double-Blind and Controlled Clinical Trial for Baihu Jiaguizhi Decoction in the Treatment of Acute Gouty Arthritis

A Randomized, Double-Blind and Controlled Clinical Trial for Baihu Jiaguizhi Decoction in the Treatment of Acute Gouty Arthritis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024974
Enrollment
Unknown
Registered
2019-08-05
Start date
2017-10-01
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gout

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adult subjects with a diagnosis of gout and with TCM diagnosis of damp-heat obstruction syndrome; 2. Male and female patients aged 18-65 years with independent behavior ability; 3. Within 48 hours of acute attack, no other similar treatment was given within 14 days before the trial; 4. eGFR >= 30ml/min/1.73m2; 5. Patients must sign informed consent to enter clinical research.

Exclusion criteria

Exclusion criteria: 1) Female patients during pregnancy or lactation; 2) Patients are allergic to drug allergy of this subject or individual hypersensitivity; 3) The level of ALT was higher than 2 times normal; 4) Patients with serious primary diseases such as heart, liver, kidney, brain, endocrine system,hematopoietic system or mental illness; 5) Patients with severe joint deformity or even labor loss ; 6) Patients received the same treatment within 2 weeks before the trial; 7) Patients have the poor compliance to difficult to complete the clinical observer.

Design outcomes

Primary

MeasureTime frame
Visual analog scale test;Evaluation of joint tenderness;Evaluation of joint swelling;Evaluation of joint activity;Ultrasound Imaging Score;blood uric acid;C-reactive protein;Erythrocyte sedimentation rate;interleukin-1ß;interleukin-6;interleukin-10;tumor necrosis factor-a;

Secondary

MeasureTime frame
TCM syndrome curative effect ratings;the total of urine uric acid in 24-hours;

Countries

China

Contacts

Public ContactGAO Jian-Dong

TCM Institute of Kidney Disease, Shanghai university of Traditional Chinese Medicine

gaojiandong@hotmail.com+86 18101819551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026